Overall Technical outlook

Price Summary

With a -11.2% collapse, Moderna, Inc. enjoyed a lousy day in the stock market.
Moderna, Inc.'s stock began trading at 150.14 on 2026-08-20, soared to 155.0, dipped to 128.61, and finished the day -11.2% down at 133.32, with 99113800 shares exchanged.
During the 52-week span, the stock hit a high of 174.38 and a low of 0.0.

Technicals


Aroon: The AROON is showing a neutral stance, not indicating a clear upward or downward trend for Moderna, Inc.. This suggests a period of market balance, where neither side is showing dominance.
MRNA aroon 886c01
Aroon chart for Moderna, Inc.


Bol. Bands: The asset's price is currently above the upper Bollinger Band, maintaining this position since its previous upward surge. This indicates strong bullish momentum and suggests that the asset could be overbought. Traders may interpret this as a sign of ongoing strength for MRNA, but they should also be cautious of a potential correction, as extended periods above the band often lead to reversals.
MRNA bbands 886c01
Bolinger Bands chart for Moderna, Inc.


Parabolic SAR: The PSAR continues its bullish outlook, establishing a support level that could help sustain the current upward trend. This level of support may act as a cushion against potential downturns, indicating continued strength in the market's bullish momentum for MRNA.
MRNA psar 886c01
Parabolic Stop and Reverse chart for Moderna, Inc.


Stochastic: The stochastic indicator for Moderna, Inc. reflects a bullish sentiment, as the K-line is above both the D-line and the 80 threshold. This setup points to strong upward momentum, implying that the market may continue to rise. Traders could consider this as an indication of sustained bullish activity.
MRNA stoch 886c01
Stochastic chart for Moderna, Inc.


Tripple Moving Agerage: The alignment of the 20, 50, and 100 moving averages points to a bearish trend, but the slopes of the 20 and 50 SMAs are starting to waver. This weakening of the bearish momentum could indicate that the market is approaching a turning point, with the possibility of a bullish reversal on the horizon. Investors should be alert for signs of a trend change as the current downtrend may be losing steam.
MRNA trippleSMA 886c01
Tripple SMA chart for Moderna, Inc.


To derive valuable insights from a company's technical performance, it is essential to first understand its fundamentals. This includes its financial health, business model, and market share. Equally important is the industry context, such as competition, consumer demand, and market trends. By examining these aspects together, investors can gain a more comprehensive view of how the company's stock behaves and whether it's aligned with its underlying value.